November 10, 2022
The tool successfully identified children with high asthma risk as young as 3 years of age. The screening tool was found to be more accurate at predicting asthma, persistent wheezing, and related emergency room visits and hospitalizations than standard screening and diagnostic tools.
November 10, 2022
Findings from research presented at the American College of Chest Physicians suggest the importance of selecting the right biologic from the start.
November 09, 2022
University of Wisconsin researchers find that people with asthma benefit from intervention that includes meditation and yoga and sustained focus on the breathing, thoughts, feelings, and bodily sensations.
October 05, 2022
Early interventions might preserve lung function, particularly in younger patients with frequent asthma exacerbations, say authors.
October 03, 2022
Program in Hidalgo, Texas, cost less than $250 per family. A study found that the intervention saved each household an average of $36 per day.
October 02, 2022
A longitudinal study aims to identify which children with asthma are more likely to suffer a loss of lung function.
September 18, 2022
Repurposing Gleevec as an asthma drug is one of the possibilities that the PrecISE trial of severe asthma is examining. The trial has an adaptive design.
September 18, 2022
Infants exposed to acid reducers may have an increased risk of developing asthma and recurrent wheeze in childhood.
August 03, 2022
Secretions of fibroblast growth factor (FGF) and granulocytic colony-stimulating growth factor (G-CSF) in airway epithelium may be to blame.
August 02, 2022
Using biomarkers for tailoring asthma treatment can reduce the frequency of asthma exacerbations. Some recent results suggest that eosinophil-guided asthma management is associated with lower annual costs than FeNO-guided management.